^
BIOMARKER:

HER-2 underexpression

i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Entrez ID:
HER-2 underexpression
Gastroesophageal Junction Adenocarcinoma
fam-trastuzumab deruxtecan-nxki
Sensitive: C2 – Inclusion Criteria
HER-2 underexpression
Breast Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive: C2 – Inclusion Criteria
HER-2 underexpression
HER2 Positive Breast Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive: C2 – Inclusion Criteria
HER-2 underexpression
Gastric Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive: C2 – Inclusion Criteria
HER-2 underexpression
Solid Tumor
KN046 + KN026
Sensitive: C3 – Early Trials
HER-2 underexpression
LUAD
ado-trastuzumab emtansine
Sensitive: C3 – Early Trials
HER-2 underexpression
HER2 Positive Breast Cancer
SYD985
Sensitive: C3 – Early Trials
HER-2 underexpression
Hormone Receptor Positive Breast Cancer
SYD985
Sensitive: C3 – Early Trials
HER-2 underexpression
Ovarian Cancer
olaparib + niraparib + SYD985
Sensitive: D – Preclinical
HER-2 underexpression
CRC
AMX-818
Sensitive: D – Preclinical
HER-2 underexpression
Breast Cancer
SAR443216
Sensitive: D – Preclinical